- Home
- HOTH vs EVGN Comparison
HOTH vs EVGN Comparison
Compare HOTH & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- EVGN
- Stock Information
- Founded
- HOTH 2017
- EVGN 1999
- Country
- HOTH United States
- EVGN Israel
- Employees
- HOTH N/A
- EVGN N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- HOTH Health Care
- EVGN Industrials
- Exchange
- HOTH Nasdaq
- EVGN Nasdaq
- Market Cap
- HOTH 8.3M
- EVGN 9.7M
- IPO Year
- HOTH 2019
- EVGN N/A
- Fundamental
- Price
- HOTH $0.97
- EVGN $1.13
- Analyst Decision
- HOTH Strong Buy
- EVGN Strong Buy
- Analyst Count
- HOTH 3
- EVGN 1
- Target Price
- HOTH $4.00
- EVGN $12.00
- AVG Volume (30 Days)
- HOTH 218.1K
- EVGN 1.1M
- Earning Date
- HOTH 05-20-2025
- EVGN 05-21-2025
- Dividend Yield
- HOTH N/A
- EVGN N/A
- EPS Growth
- HOTH N/A
- EVGN N/A
- EPS
- HOTH N/A
- EVGN N/A
- Revenue
- HOTH N/A
- EVGN $8,511,000.00
- Revenue This Year
- HOTH N/A
- EVGN $68.62
- Revenue Next Year
- HOTH N/A
- EVGN $66.92
- P/E Ratio
- HOTH N/A
- EVGN N/A
- Revenue Growth
- HOTH N/A
- EVGN 50.90
- 52 Week Low
- HOTH $0.58
- EVGN $0.95
- 52 Week High
- HOTH $3.80
- EVGN $9.00
- Technical
- Relative Strength Index (RSI)
- HOTH 59.33
- EVGN 46.45
- Support Level
- HOTH $0.85
- EVGN $1.09
- Resistance Level
- HOTH $0.95
- EVGN $1.22
- Average True Range (ATR)
- HOTH 0.06
- EVGN 0.10
- MACD
- HOTH 0.02
- EVGN 0.01
- Stochastic Oscillator
- HOTH 95.42
- EVGN 27.59
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.